Kaoru Hamada

2.9k citations
54 papers · 2.4k · 2 hit papers · h-index 17

Impact in

  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Pancreatic and Hepatic Oncology Research
  • Immunology top 2%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • Immune cells in cancer

Papers in

    • Respiratory and Cough-Related Research 4
    • Lung Cancer Treatments and Mutations 4
    • Tracheal and airway disorders 3
    • Asthma and respiratory diseases 5
    • Nitric Oxide and Endothelin Effects 5

Kaoru Hamada

51 papers receiving 2.3k citations

Kaoru Hamada's Hit Papers

Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic Cancer 2007 · 729 citations
7290+7+14Years since publication200400600

Peers

Kaoru Hamada
Comparison fields: 5 of 119
  • Oncology 1.3k
  • Immunology 924
  • Pulmonary and Respiratory Medicine 516
  • Endocrine and Autonomic Systems 84
  • Physiology 257
Replace Hirohisa Yoshizawa with:
Hirohisa Yoshizawa Japan
Nadeem Moghal United Kingdom
Margaret A. Schwarz United States
Paola Ferrari Italy
Wilfred T.V. Germeraad Netherlands
Jennifer L. Hsu United States
Krzysztof Książek Poland
Susan L. Kelley United States
Subhankar Chakraborty United States
Gotaro Toda Japan
Kaoru Hamada relative to Hirohisa Yoshizawa Japan Hirohisa Yoshizawa's profile →
Citations per field
00.5×1.5×
Hirohisa Yoshizawa · 1×
Citations per year

Countries citing papers authored by Kaoru Hamada

Since Specialization
Citations

This map shows the geographic impact of Kaoru Hamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaoru Hamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaoru Hamada more than expected).

Fields of papers citing papers by Kaoru Hamada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaoru Hamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaoru Hamada. The network helps show where Kaoru Hamada may publish in the future.

Co-authors

The 25 scholars most cited alongside Kaoru Hamada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kaoru Hamada Line = papers co-authored together Kaoru Hamada links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic Cancer
Hit paper breakdown →
2007729
2
Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer
Hit paper breakdown →
2005660
3 1999183
4 1991105
5 200768
6 200560
7 199754
8 199248
9 199942
10 200440
11 200540
12 198738
13 200735
14 199935
15 199935
16 200134
17 200125
18 199212
19 200511
20
Proliferation of erythromycin-stimulated mouse peritoneal macrophages in the absence of exogenous growth factors.
199411

About Kaoru Hamada

Kaoru Hamada is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Oncology, Molecular Biology and Immunology, having authored 54 papers that have together received 2.4k indexed citations. Recurring topics across this work include Pediatric health and respiratory diseases (6 papers), Asthma and respiratory diseases (5 papers), Nitric Oxide and Endothelin Effects (5 papers), Surfactants and Colloidal Systems (4 papers), Respiratory and Cough-Related Research (4 papers), Lung Cancer Research Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Tracheal and airway disorders (3 papers). The work is most often cited by research in Oncology (1.3k citations), Immunology (924 citations), Pulmonary and Respiratory Medicine (516 citations), Endocrine and Autonomic Systems (84 citations) and Physiology (257 citations). Kaoru Hamada has collaborated with scholars based in Japan, United States and Singapore. Frequent co-authors include Masayuki Sho, Yoshiyuki Nakajima, Miyuki Azuma, Hideo Yagita∥, Hiromichi Kanehiro, Takeo Nomi, Atsushi Kubo, Takahiro Akahori, Koji Enomoto and Shinji Nakamura. Their work appears in journals such as Chemotherapy, Clinical Cancer Research, European Journal of Dermatology, American Journal of Physiology-Lung Cellular and Molecular Physiology and Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact